Darlene Deptula-Hicks

IMCOR Pharmaceutical Co. is a development-stage pharmaceutical company focused on developing medical imaging pharmaceutical products. Currently, the company's core business focus has evolved from an operating entity conducting research and development, manufacturing and limited selling activities. The company was founded by H. Craig Dees and Eric A. Wachter on December 28, 1994 and is headquartered in San Diego, CA.

ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA.

GCA Corp. manufactures and wholesales memory chips. The company is based in Bedford, MA.

Part of Linde Plc, EHVIL Dissentients Ltd. is a leading developer and manufacturer of sophisticated vacuum products, abatement solutions, and related value-added services. Founded in 1950, the company is based in Guildford, UK. Edwards provides vacuum and abatement service solutions for semiconductor manufacturers to boost productivity, cost efficiency, and minimize the environmental impact. The British company's products are integral to manufacturing processes for semiconductors, flat panel displays, LEDs, and solar cells, and are used within an increasingly diverse range of industrial processes including power, glass and other coating applications, steel and other metallurgy, pharmaceutical and chemical, and for both scientific instruments and a wide range of R & D applications. Edwards' integrated solution allows them to provide their customers with the advantages of product and service repeatability that brings to their customers productivity, safety, and environmental reassurance.

Part of HOYA Corp., Microline Surgical, Inc. is a medical technology company based in Beverly, MA. The company specializes in designing, developing, and manufacturing advanced surgical instruments such as graspers, dissectors, scissors, and specialized instruments tailored to specific surgical procedures. The company's instruments are designed to enhance surgical outcomes, improve customer’s sustainability results, and reduce the cost of care. Microline Surgical partners with healthcare providers to streamline intraoperative efficiencies and drive significant cost savings.

Pieris AG develops and markets Anticalin-brand proteins. The firm specializes in the research and development of its Anticalin technology, with focus on deriving therapeutic proteins from human lipocalins. It focuses on solving pharmacological and pharmaceutical limitations of both protein- and non-protein-based drug platforms. It offers a pipeline of Anticalin therapeutics that has active and multi-program research and development collaborations with biopharmaceutical companies. The company was founded by Arne Skerra, Steffen Schlehuber, and Claus Schalper in 2001 and is headquartered in Freising, Germany.

F-Star Therapeutics, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA.

F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm's product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor evasion pathways. The company was founded on October 7, 2002 and is headquartered in Cambridge, the United Kingdom.

Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada.

Abcuro, Inc. develops bio-therapeutics for the treatment of autoimmunity and cancer. the company was founded in 2015 and is headquartered in Newton, MA.

Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC.

Dance Biopharm Holdings, Inc. engages in providing health care services. The company was founded by John Stuart Patton in 2010 and is headquartered in San Francisco, CA.